META vs TRDA · P/E 29, rev $200.97B vs P/E 12, rev $210.8M
Meta Platforms Inc. (META) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
META currently screens at market cap $1.64T and trailing P/E 28.8. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the META and TRDA stock pages for the full models.
Not investment advice.